Comparing combination and single-agent therapy for the treatment of pemphigus: a retrospective cohort study

Published: 27 January 2025| Version 1 | DOI: 10.17632/3dngby9nhx.1
Contributor:
Soahum Bagchi

Description

Supplementary data (figure and tables) to the reterospective cohort study: - Address issues in clinical practice – Mono vs multi-modal therapy is given in terms of multiple therapeutic agents in pemphigus vulgaris and foliaceous.

Files

Institutions

Beth Israel Deaconess Medical Center, Harvard Medical School, Massachusetts General Hospital

Categories

Dermatology, Rituximab, Mycophenolate Mofetil, Combination Therapy, Monotherapy, Pemphigus

Licence